It is a pharma private limited company based in New Delhi, Delhi, India, established in 2013.
2013 | New Delhi, Delhi, India | AmalgamatedAshwin Pharmaceuticals Private Limited, a amalgamated private limited company, was established on 01 November 2013 in New Delhi, Delhi, India. Engaging in drug formulation & development within the manufacturing sector, it holds CIN: U51101DL2013PTC259819. Registered under ROC Roc Delhi. it is unlisted. It has an authorized capital of ₹1.40 Cr and a paid-up capital of ₹9.40 M.
It upholds a compliant status. Its leadership includes Aditya Kumar Bhandari (Director), Pranav Srivastava (Director). Past directors included Aswani Kumar, Jhantu Mandal, Pranav Srivastava. Its latest AGM occurred on 27 September 2021, with the balance sheet filed on 31 March 2021. It is based at C-30 Panchsheel Enclave, New Delhi, Delhi, 110017.
U51101DL2013PTC259819
259819
01 November 2013
₹1.40 Cr
₹9.40 M
Roc Delhi
Unlisted
Amalgamated
Explore comprehensive insights into Ashwin Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Aditya Kumar Bhandari | Director | 12 Sep 2018 | Current |
| Pranav Srivastava | Director | 28 Apr 2016 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 28 Apr 2016 | Past |
| Pramod Abcsdd | Director | 14 Sep 2018 | Past |
| Pramod Abcsdd | Additional Director | 30 Sep 2016 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Ashwin Pharmaceuticals Private Limited, for the financial year ended 2018, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 219.04% decrease in profit. The company's net worth dipped by a decrease of 0.03%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2018, Ashwin Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Ashwin Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Ashwin Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Ashwin Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Ashwin Pharmaceuticals Private Limited last Annual general meeting of members was held on 27 Sep 2021 as per latest MCA records. was recorded as a recent event.
Progress on Ashwin Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2021 with Roc Delhi. was documented.
Progress on Aditya Kumar Bhandari was appointed as a Director was appointed as a Director on 12 Sep 2018 & has been associated with this company since 7 years 2 months . was documented.
The activity Pranav Srivastava was appointed as a Director was appointed as a Director on 28 Apr 2016 & has been associated with this company since 9 years 7 months . was completed.
Ashwin Pharmaceuticals Private Limited was registered on 01 Nov 2013 with Roc Delhi & aged 12 years 29 days as per MCA records. was recorded as a recent event.
The CIN of Ashwin Pharmaceuticals Private Limited is U51101DL2013PTC259819.
Ashwin Pharmaceuticals Private Limited is headquartered at C-30 Panchsheel Enclave, New Delhi, Delhi, 110017.
Ashwin Pharmaceuticals Private Limited was incorporated on 01 November 2013.
The current directors of Ashwin Pharmaceuticals Private Limited are
The primary industry of Ashwin Pharmaceuticals Private Limited is Manufacturing.
Ashwin Pharmaceuticals Private Limited is unlisted.
The authorized capital of Ashwin Pharmaceuticals Private Limited is ₹1.40 Cr, and the paid-up capital is ₹9.40 M.
The compliance status of Ashwin Pharmaceuticals Private Limited is Compliant.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX